Idiopathic Pulmonary Fibrosis Comorbidities Discussed By Researchers


pf_ipf researchers

A team of researchers from the Department of Clinical and Experimental Medicine at the University of Catania, Italy recently reviewed the co-occurrence of additional diseases in Idiopathic Pulmonary Fibrosis and their current therapeutic strategies. The study, entitled “IPF, comorbidities and management implications,“ was published in the Sarcoidosis Vasculitis and Diffuse Lung Disease journal.

IPF is not curable and available treatments are only used to aid patients in breathing. IPF is associated with a wide variety of comorbidities of the respiratory and non-respiratory system. In this recent study, the team focused on three common diseases linked to IPF diseases — cardiovascular disorders, lung cancer and emphysema.


Read more about it:

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Leave a Comment

Your email address will not be published. Required fields are marked *